Publications by authors named "Khatami R"

Background: Stimulants are potent treatments for central hypersomnolence disorders or attention-deficit/hyperactivity disorders/attention deficit disorders but concerns have been raised about their potential negative consequences and their increasing prescription rates.

Objective: We aimed to describe stimulant prescription trends in Switzerland from 2014 to 2021. Second, we aimed to analyze the characteristics of individuals who received stimulant prescriptions in 2021 and investigate the link between stimulant prescriptions and hospitalization rates in 2021, using hospitalization as a potential indicator of adverse health outcomes.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers analyzed data from over 1500 patients and found that women reported higher sleepiness on the Epworth Sleepiness Scale compared to men, with specific age-related trends observed in different patient groups.
  • * Notably, in women with narcoleptic conditions, an increase in daytime sleepiness was linked to age, while weight gain appeared later, suggesting a complex relationship that warrants further research for targeted treatment approaches.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the frequency of psychiatric disorders in patients with narcolepsy type-1 (NT1) and other central disorders of hypersomnolence (OCH), finding that 38 out of 90 patients (27% of NT1 and 48% of OCH) had at least one psychiatric issue.
  • Major depressive episodes and suicidality were the most common psychiatric conditions observed, with a notable prevalence among females.
  • Those with psychiatric comorbidities experienced more severe fatigue, apathy, disturbed sleep, and poorer overall quality of life, indicating a negative impact on their daily functioning due to the combination of these disorders and hypersomnolence symptoms.
View Article and Find Full Text PDF
Article Synopsis
  • The Swiss Primary Hypersomnolence and Narcolepsy Cohort Study (SPHYNCS) aims to discover new biomarkers for central disorders of hypersomnolence, particularly focusing on narcolepsy type 1 (NT1) and its distinction from healthy controls.
  • Researchers used Fitbit smartwatches to gather data on physical activity, heart rate, and sleep over a year, achieving an impressive adherence rate of 80% among participants.
  • Findings revealed that NT1 patients showed increased sleep fragmentation and specific changes in sleep and heart rate metrics compared to healthy controls, indicating the potential for wearable technology to assist in the diagnosis and management of narcolepsy in the future.
View Article and Find Full Text PDF
Article Synopsis
  • * Researchers reviewed medical records from 290 individuals with NT1 and 115 with NT2 or IH to analyze immunological events, such as infections and vaccinations, that occurred before the onset of hypersomnolence.
  • * Results indicate that NT1 shows a stronger association with flu infections and vaccinations, whereas NT2 and IH are linked to other viral infections; the study highlights the need for further investigation into these distinct immunological triggers.
View Article and Find Full Text PDF

Objective: The aim of this study was to evaluate the impact of social support and religiosity/spirituality (R/S) on the recovery from an acute cardiac event or cardiac surgery during cardiac rehabilitation (CR).

Methods: In this prospective study, a convenience sample of 159 patients participating in a CR program were enrolled. Religiosity/spirituality, social support, anxiety, depression, health related quality of life (QoL), and exercise capacity (6-min walk test, cycle ergometer test) were assessed.

View Article and Find Full Text PDF

Objective: /Background: The change in cerebral hemodynamics induced by sleep apneas and hypopneas may contribute to the daytime sleepiness in patients with obstructive sleep apnea (OSA). However, previous studies failed to discovery their relationship. We propose and test a new parameter, the cumulative brain oxygen desaturation, which may contribute to OSA patient's daytime sleepiness.

View Article and Find Full Text PDF

We present a new study design aiming to enhance the understanding of the mechanism by which continuous theta burst stimulation (cTBS) or intermittent theta burst stimulation (iTBS) paradigms elicit cortical modulation. Using near-infrared spectroscopy (NIRS), we compared the cortical hemodynamics of the previously inhibited (after cTBS) or excited (after iTBS) left primary motor cortex (M1) as elicited by single-pulse TMS (spTMS) in a cross-over design. Mean relative changes in hemodynamics within 6 s of the stimulus were compared using a two-sample -test ( < 0.

View Article and Find Full Text PDF

Objectives/background: Narcolepsy type 1 (NT1) is an immune-mediated disorder characterized by excessive daytime sleepiness, cataplexy, low levels of hypocretin-1 in the cerebrospinal fluid, and a strong association with the HLA DQB1*06:02 allele. There is evidence for streptococcal infections as one pathogenic factor that may lead to NT1 as part of a multifactorial pathogenesis. Elevated titers of Antistreptolysin-O antibodies and increased inflammatory activity in response to streptococci antigens have been described in patients with NT1.

View Article and Find Full Text PDF
Article Synopsis
  • * The study analyzed over 6,000 NT1 cases and identified new genetic associations (e.g., CD207, NAB1) tied to immune response, particularly involving T cells.
  • * Results suggest that genetic factors in NT1 also relate to other autoimmune diseases, indicating a shared immune mechanism influenced by environmental factors like infections and vaccinations.
View Article and Find Full Text PDF

Purpose: Narcolepsy type-1 (NT1) is a rare chronic neurological sleep disorder with excessive daytime sleepiness (EDS) as usual first and cataplexy as pathognomonic symptom. Shortening the NT1 diagnostic delay is the key to reduce disease burden and related low quality of life. Here we investigated the changes of diagnostic delay over the diagnostic years (1990-2018) and the factors associated with the delay in Europe.

View Article and Find Full Text PDF

Background And Objectives: Recent studies fueled doubts as to whether all currently defined central disorders of hypersomnolence are stable entities, especially narcolepsy type 2 and idiopathic hypersomnia. New reliable biomarkers are needed, and the question arises of whether current diagnostic criteria of hypersomnolence disorders should be reassessed. The main aim of this data-driven observational study was to see whether data-driven algorithms would segregate narcolepsy type 1 and identify more reliable subgrouping of individuals without cataplexy with new clinical biomarkers.

View Article and Find Full Text PDF

Obstructive sleep apnea (OSA) is a common sleep disorder, and continuous positive airway pressure (CPAP) is the most effective treatment. Poor adherence is one of the major challenges in CPAP therapy. The recent boom of wearable optical sensors measuring oxygen saturation makes at-home multiple-night CPAP titrations possible, which may essentially improve the adherence of CPAP therapy by optimizing its pressure in a real-life setting economically.

View Article and Find Full Text PDF

Obstructive sleep apnea syndrome (OSAS) is a common sleep disorder. Severe OSAS defined as apnea-hypopnea index (AHI) ≥ 30/h is a risk factor for developing cerebro-cardiovascular diseases. The mechanisms of how repetitive sleep apneas/hypopneas damage cerebral hemodynamics are still not well understood.

View Article and Find Full Text PDF

Background: Severe and critically ill COVID-19 patients frequently need pulmonary rehabilitation (PR) after hospitalization. However, little is known about the effectiveness of PR in COVID-19 patients.

Methods: We compared the performances in the six-min walk test (6MWT), chronic respiratory questionnaire (CRQ), and Functional Independence Measure (FIM) from inpatient PR between 51 COVID-19 patients and 51 other patients with common pneumonia.

View Article and Find Full Text PDF

Background: Obstructive sleep apnea (OSA) is the most prevalent respiratory sleep disorder occurring in 9% to 38% of the general population. About 90% of patients with suspected OSA remain undiagnosed due to the lack of sleep laboratories or specialists and the high cost of gold-standard in-lab polysomnography diagnosis, leading to a decreased quality of life and increased health care burden in cardio- and cerebrovascular diseases. Wearable sleep trackers like smartwatches and armbands are booming, creating a hope for cost-efficient at-home OSA diagnosis and assessment of treatment (eg, continuous positive airway pressure [CPAP] therapy) effectiveness.

View Article and Find Full Text PDF
Article Synopsis
  • Narcolepsy is a rare sleep disorder believed to be autoimmune, demanding ongoing treatment, and this paper offers guidelines for managing the condition in both adults and children.
  • A task force of 18 specialists evaluated over 10,000 references to create evidence-based recommendations, which include treatment options like scheduled naps and medications such as modafinil and sodium oxybate.
  • The guidelines emphasize personalized treatment based on individual symptoms and circumstances, highlighting the importance of both non-drug and drug approaches in managing narcolepsy effectively.
View Article and Find Full Text PDF
Article Synopsis
  • Narcolepsy is a rare disorder often requiring lifelong treatment, and this paper provides evidence-based guidelines for managing the condition in both adults and children.
  • A task force of narcolepsy specialists used systematic literature reviews to develop recommendations for treating symptoms like excessive daytime sleepiness (EDS) and cataplexy, focusing on different medication options and strategies.
  • The guidelines emphasize tailored treatment plans based on individual symptoms, comorbidities, and drug interaction risks, reflecting an increasing range of effective treatments available for narcolepsy.
View Article and Find Full Text PDF

Narcolepsy type 1 (NT1) is a disorder with well-established markers and a suspected autoimmune aetiology. Conversely, the narcoleptic borderland (NBL) disorders, including narcolepsy type 2, idiopathic hypersomnia, insufficient sleep syndrome and hypersomnia associated with a psychiatric disorder, lack well-defined markers and remain controversial in terms of aetiology, diagnosis and management. The Swiss Primary Hypersomnolence and Narcolepsy Cohort Study (SPHYNCS) is a comprehensive multicentre cohort study, which will investigate the clinical picture, pathophysiology and long-term course of NT1 and the NBL.

View Article and Find Full Text PDF

Background And Purpose: Insomnia is a common and debilitating disorder that is frequently associated with important consequences for physical health and well-being.

Methods: An international expert group considered the current state of knowledge based on the most relevant publications in the previous 5 years, discussed the current challenges in the field of insomnia and identified future priorities.

Results: The association of trajectories of insomnia with subsequent quality of life, health and mortality should be investigated in large populations.

View Article and Find Full Text PDF

Background: Some epilepsy syndromes (sleep-related epilepsies [SRE]) have a strong link with sleep. Comorbid sleep disorders are common in patients with SRE and can exert a negative impact on seizure control and quality of life.

Purposes: To define the standard procedures for the diagnostic pathway of patients with possible SRE (scenario 1) and the general management of patients with SRE and comorbidity with sleep disorders (scenario 2).

View Article and Find Full Text PDF